Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization

Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer

(2010) Marco Colleoni et al.   JOURNAL OF CLINICAL ONCOLOGY

The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer

(2009) Marieke E. Straver et al.   BREAST CANCER RESEARCH AND TREATMENT

Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status

(2009) Yeon Hee Park et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Endothelial Cells Form a Phalanx to Block Tumor Metastasis

(2009) Victoria L. Bautch   CELL

Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization

(2009) Massimiliano Mazzone et al.   CELL

Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

(2009) Joel S. Parker et al.   JOURNAL OF CLINICAL ONCOLOGY

Alterations in the TOP2A and HER2 Genes: Association With Adjuvant Anthracycline Sensitivity in Human Breast Cancers

(2009) D. J. Slamon et al.   JNCI-Journal of the National Cancer Institute

Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy

(2009) F. P. O'Malley et al.   JNCI-Journal of the National Cancer Institute

HER-2 and Topoisomerase II As Predictors of Response to Chemotherapy

(2008) Kathleen I. Pritchard et al.   JOURNAL OF CLINICAL ONCOLOGY

Basal-Like Breast Cancer: A Critical Review

(2008) Emad A. Rakha et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical Application of the 70-Gene Profile: The MINDACT Trial

(2008) Fatima Cardoso et al.   JOURNAL OF CLINICAL ONCOLOGY

Stromal gene expression predicts clinical outcome in breast cancer

(2008) Greg Finak et al.   NATURE MEDICINE